• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证慢性特发性荨麻疹患者电子和纸质版荨麻疹患者日常日记的测量等效性。

Demonstrating measurement equivalence of the electronic and paper formats of the Urticaria Patient Daily Diary in patients with chronic idiopathic urticaria.

机构信息

Oxford Outcomes, Inc., An ICON plc Company, 7315 Wisconsin Ave., Suite 250W, Bethesda, MD, 20814, USA,

出版信息

Patient. 2013;6(3):225-31. doi: 10.1007/s40271-013-0021-4.

DOI:10.1007/s40271-013-0021-4
PMID:23918000
Abstract

BACKGROUND

The Urticaria Patient Daily Diary (UPDD), originally developed on paper, is a measure of key symptoms of chronic idiopathic urticaria (CIU). The development of the electronic version (eUPDD) involved moderate modifications to the appearance of the paper version.

OBJECTIVE

This study assessed the measurement equivalence of the electronic and paper versions of the UPDD in a sample of patients with CIU.

METHODS

This was a cross-over study of patients with moderate-severe CIU refractory to H1 antihistamines. Patients were randomized to either the eUPDD followed by the paper UPDD or vice versa. The UPDD includes morning and evening questions; both sets were administered together in this study. An hour-long filler task was given between paper and electronic administrations. Patients with stable symptoms between the two assessments were included in the analyses. Cohen's kappa coefficients and intraclass correlation coefficients (ICC) were computed as applicable to assess equivalence.

RESULTS

A total of 91 patients participated (mean age 43 years, 79.1 % female). Symptoms were stable between assessments for 67-74 (74-81 %) patients (varied by symptom). Kappa coefficients ranged from 0.82 to 1.00 for the individual UPDD items. For the Urticaria Activity Score (the sum of the 'itch severity' and 'number of hives' item scores) the ICC was 0.90 for the morning (Wilcoxon p = 0.331) and 0.95 for the evening (Wilcoxon p = 0.836).

CONCLUSIONS

All test-retest statistics in this study were well above the accepted threshold, indicating excellent agreement between the two administration methods. Findings support the measurement equivalence of the electronic and paper versions of the UPDD to measure CIU symptoms.

摘要

背景

最初以纸质形式开发的荨麻疹患者日常日记(UPDD)是慢性特发性荨麻疹(CIU)关键症状的一种测量手段。电子版本(eUPDD)的开发涉及对纸质版本外观的适度修改。

目的

本研究旨在评估 CIU 患者样本中 UPDD 的电子和纸质版本的测量等效性。

方法

这是一项对 H1 抗组胺治疗难治性中度至重度 CIU 患者的交叉研究。患者随机分为 eUPDD 组和纸质 UPDD 组,或反之。UPDD 包括早晨和晚上的问题;在这项研究中同时进行了这两套问题。在纸质和电子管理之间进行了长达一个小时的填充任务。仅纳入两次评估时症状稳定的患者进行分析。

结果

共有 91 名患者参与(平均年龄 43 岁,79.1%为女性)。67-74 项(因症状而异)患者的症状在两次评估之间稳定。个体 UPDD 项目的kappa 系数范围为 0.82 至 1.00。对于荨麻疹活动评分(“瘙痒严重程度”和“风团数量”项目评分之和),早晨的 ICC 为 0.90(Wilcoxon p = 0.331),晚上的 ICC 为 0.95(Wilcoxon p = 0.836)。

结论

本研究中的所有测试 - 重测统计数据均远高于可接受的阈值,表明两种管理方法之间具有极好的一致性。研究结果支持 UPDD 的电子和纸质版本在测量 CIU 症状方面具有测量等效性。

相似文献

1
Demonstrating measurement equivalence of the electronic and paper formats of the Urticaria Patient Daily Diary in patients with chronic idiopathic urticaria.验证慢性特发性荨麻疹患者电子和纸质版荨麻疹患者日常日记的测量等效性。
Patient. 2013;6(3):225-31. doi: 10.1007/s40271-013-0021-4.
2
Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool.荨麻疹活动和影响衡量标准的有效性和响应性:一种新的患者报告工具。
Ann Allergy Asthma Immunol. 2018 Jun;120(6):641-647. doi: 10.1016/j.anai.2018.03.012. Epub 2018 Mar 19.
3
Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria.氨苯砜治疗抗组胺药难治性慢性特发性荨麻疹的双盲安慰剂对照试验
J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):601-6. doi: 10.1016/j.jaip.2014.06.004.
4
Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria.评估慢性特发性荨麻疹患者的荨麻疹活动评分和其他疾病活动衡量标准的最小重要差异。
Ann Allergy Asthma Immunol. 2012 Jan;108(1):20-24. doi: 10.1016/j.anai.2011.09.008. Epub 2011 Nov 2.
5
The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.白三烯受体拮抗剂孟鲁司特治疗慢性特发性荨麻疹:一项单盲、安慰剂对照、交叉临床研究。
J Allergy Clin Immunol. 2002 Sep;110(3):484-8. doi: 10.1067/mai.2002.126676.
6
The minimal important difference for measures of urticaria disease activity: Updated findings.荨麻疹疾病活动度测量的最小重要差异:最新发现。
Allergy Asthma Proc. 2015 Sep-Oct;36(5):394-8. doi: 10.2500/aap.2015.36.3873.
7
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.盐酸非索非那定治疗慢性特发性荨麻疹的双盲、安慰剂对照试验。
J Allergy Clin Immunol. 1999 Nov;104(5):1071-8. doi: 10.1016/s0091-6749(99)70091-6.
8
Adaptation and validation of the Urticaria Patient Daily Diary for adolescents.青少年荨麻疹患者日常日记的适应和验证。
Allergy Asthma Proc. 2012 Mar-Apr;33(2):186-90. doi: 10.2500/aap.2012.33.3508.
9
Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.一项随机安慰剂对照试验,比较地氯雷他定和孟鲁司特单药治疗以及地氯雷他定联合孟鲁司特治疗慢性特发性荨麻疹的疗效。
J Allergy Clin Immunol. 2004 Sep;114(3):619-25. doi: 10.1016/j.jaci.2004.06.018.
10
Development of a daily diary for patients with chronic idiopathic urticaria.慢性特发性荨麻疹患者日记的开发。
Ann Allergy Asthma Immunol. 2010 Aug;105(2):142-8. doi: 10.1016/j.anai.2010.06.011.

引用本文的文献

1
Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.ASSURE-CSU 分析:慢性自发性荨麻疹中的血管性水肿漏诊率高,影响大。
Allergy. 2018 Aug;73(8):1724-1734. doi: 10.1111/all.13430.
2
Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study.每日一次和每日两次给药方案获得的 7 天荨麻疹活动评分(UAS7)值的比较:ASSURE-CSU 研究结果。
Am J Clin Dermatol. 2018 Apr;19(2):267-274. doi: 10.1007/s40257-017-0331-8.
3
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.

本文引用的文献

1
Adaptation and validation of the Urticaria Patient Daily Diary for adolescents.青少年荨麻疹患者日常日记的适应和验证。
Allergy Asthma Proc. 2012 Mar-Apr;33(2):186-90. doi: 10.2500/aap.2012.33.3508.
2
Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria.评估慢性特发性荨麻疹患者的荨麻疹活动评分和其他疾病活动衡量标准的最小重要差异。
Ann Allergy Asthma Immunol. 2012 Jan;108(1):20-24. doi: 10.1016/j.anai.2011.09.008. Epub 2011 Nov 2.
3
Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review.
慢性自发性荨麻疹负担沉重:ASSURE-CSU 的真实世界证据。
Allergy. 2017 Dec;72(12):2005-2016. doi: 10.1111/all.13209. Epub 2017 Jul 10.
白三烯受体拮抗剂单药或联合抗组胺药治疗慢性荨麻疹的系统评价。
J Asthma Allergy. 2008 Dec 9;2:9-16. doi: 10.2147/jaa.s3236.
4
Development of a daily diary for patients with chronic idiopathic urticaria.慢性特发性荨麻疹患者日记的开发。
Ann Allergy Asthma Immunol. 2010 Aug;105(2):142-8. doi: 10.1016/j.anai.2010.06.011.
5
Progress and challenges in the understanding of chronic urticaria.慢性荨麻疹的研究进展与挑战。
Allergy Asthma Clin Immunol. 2007 Mar 15;3(1):31-5. doi: 10.1186/1710-1492-3-1-31.
6
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.关于支持电子和纸质患者报告结局(PRO)测量等效性所需证据的建议:国际药物经济学与结果研究协会(ISPOR)电子PRO良好研究实践工作组报告
Value Health. 2009 Jun;12(4):419-29. doi: 10.1111/j.1524-4733.2008.00470.x. Epub 2008 Nov 11.
7
Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.加权kappa系数:用于衡量名义尺度上的一致性,并考虑了尺度不一致或部分得分的情况。
Psychol Bull. 1968 Oct;70(4):213-20. doi: 10.1037/h0026256.
8
Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.白三烯受体拮抗剂与抗H1受体拮抗剂联合治疗慢性特发性荨麻疹的疗效
J Dermatolog Treat. 2009;20(4):194-7. doi: 10.1080/09546630802607495.
9
Intraclass correlations: uses in assessing rater reliability.组内相关系数:在评估评分者可靠性中的应用。
Psychol Bull. 1979 Mar;86(2):420-8. doi: 10.1037//0033-2909.86.2.420.
10
Treatment of chronic autoimmune urticaria with omalizumab.用奥马珠单抗治疗慢性自身免疫性荨麻疹。
J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006.